Search

Search Constraints

You searched for: Academic Unit Neurology Remove constraint Academic Unit: Neurology Subject Alzheimer's disease Remove constraint Subject: Alzheimer's disease Start Over

Search Results

1. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance

2. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease

7. TREM2 is associated with increased risk for Alzheimer’s disease in African Americans

11. Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment

24. Plasma Amyloid Beta-Peptide 1-42 and Incipient Alzheimer's Disease

26. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need

36. Motor Signs Predict Poor Outcomes in Alzheimer Disease

37. Motor Signs During the Course of Alzheimer Disease

53. Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score

55. Fine Mapping of 10q and 18q for Familial Alzheimer's Disease in Caribbean Hispanics

57. Excess Synaptojanin 1 Contributes to Place Cell Dysfunction and Memory Deficits in the Aging Hippocampus in Three Types of Alzheimer’s Disease

70. Dependence as a Unifying Construct in Defining Alzheimer's Disease Severity

71. Covariance PET Patterns in Early Alzheimer's Disease and Subjects with Cognitive Impairment but No Dementia: Utility in Group Discrimination and Correlations with Functional Performance

80. Benfotiamine and Cognitive Decline in Alzheimer’s Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial

82. Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels

90. Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial